Reconocimiento temprano | 04 AGO 19

Adenomas hipofisarios

Suelen ser asintomáticos o bien tienen síntomas inespecíficos y esto puede ser causa de retraso en el diagnóstico
12
18
Autor: Pal A, Leaver L, Wass J BMJ 2019; 365:l2091
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1 Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 2007; 156:203-16. 10.1530/eje.1.02326 17287410

2 Kreitschmann-Andermahr I, Siegel S, Weber Carneiro R, Maubach JM, Harbeck B, Brabant G. Headache and pituitary disease: a systematic review. Clin Endocrinol (Oxf) 2013;79:760-9. 10.1111/cen.12314 23941570

3 Levy MJ. The association of pituitary tumors and headache. Curr Neurol Neurosci Rep 2011;11:164-70. 10.1007/s11910-010-0166-7 21128024

4 Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary apoplexy. Endocr Rev 2015;36:622-45. 10.1210/er.2015-1042 26414232

5 Arafah BM. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1986; 62:1173-9. 10.1210/jcem-62-6-1173 3009521

6 Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 2010;72:203-8. 10.1111/j.1365-2265.2009.03626.x 19473180

7 Zarool-Hassan R, Conaglen HM, Conaglen JV, Elston MS. Symptoms and signs of acromegaly: an ongoing need to raise awareness among healthcare practitioners. J Prim

Health Care 2016; 8:157-63. 10.1071/HC15033 27477558

8 Kreitschmann-Andermahr I, Psaras T, Tsiogka M, etal . From first symptoms to final diagnosis of Cushing’s disease: experiences of 176 patients. Eur J Endocrinol 2015; 172:285-9. 10.1530/EJE-14-0766 25501963

9 Nieman LK. Update on subclinical Cushing’s syndrome. Curr Opin Endocrinol Diabetes Obes 2015;22:180-4. 10.1097/MED.0000000000000159 25887388

10 Yoo F, Chan C, Kuan EC, Bergsneider M, Wang MB. Comparison of male and female prolactinoma patients requiring surgical intervention. J Neurol Surg B Skull Base 2018; 79:394-400. 10.1055/s-0037-1615748 30009121

11 Schaller B. Gender-related differences in prolactinomas. A clinicopathological study. Neuro Endocrinol Lett 2005;26:152-9.15855888

12 Drange MR, Fram NR, Herman-Bonert V, Melmed S. Pituitary Tumor Registry: a novel clinical resource. J Clin Endocrinol Metab 2000;85:168-74.10634382

13 Andela CD, Scharloo M, Pereira AM, Kaptein AA, Biermasz NR. Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 2015; 18:752-76. 10.1007/s11102-015-0636-7 25605584

14 Muskens IS, Zamanipoor Najafabadi AH, Briceno V, etal. Visual outcomes after endoscopic endonasal pituitary adenoma resection: a systematic review and meta-analysis. Pituitary 2017;20:539-52. 10.1007/s11102-017-0815-9 28643208

15 Thotakura AK, Patibandla MR, Panigrahi MK, Addagada GC. Predictors of visual outcome with transsphenoidal excision of pituitary adenomas having suprasellar extension: a prospective series of 100 cases and brief review of the literature. Asian J Neurosurg 2017;12:1-5. 10.4103/1793-5482.149995 28413523

16 Tasan E, Hanimoglu H, Turgut S, Ilhan M, Evran S, Kaynar M. Rapid improvement in visual loss with cabergoline treatment in a giant prolactinoma case: 5 years survey. Neuroendocrinol Lett 2015; 36:28-30.

17 Shimon I, Sosa E, Mendoza V, etal . Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas Pituitary 2016;19:429-36.

18 Surchi H, Jafar-Mohammadi B, Pal A, Cudlip S, Grossman AB. Local optometrists are a major source of referrals to a pituitary tumour clinic. Endocr Relat Cancer 2017; 24:L33-4.19 Molitch ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am 2008; 37:151-71, xi. 10.1016/j.ecl.2007.10.011 18226735

20 Freda PU, Beckers AM, Katznelson L, etal. Endocrine Society. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:894-904.10.1210/jc.2010-1048 21474686

21 Ezzat S, Asa SL, Couldwell WT, etal . The prevalence of pituitary adenomas: a systematic review. Cancer 2004; 101:613-9. 10.1002/cncr.20412 15274075

22 Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 2010;72:377-82. 10.1111/j.1365-2265.2009.03667.x 19650784

23 Agustsson TT, Baldvinsdottir T, Jonasson JG, etal . The epidemiology of pituitaryadenomas in Iceland, 1955-2012: a nationwide population-based study. Eur J Endocrinol 2015;173:655-64. 10.1530/EJE-15-0189 26423473

24 Ónnestam L, Berinder K, Burman P, etal . National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab 2013; 98:626-35.10.1210/jc.2012-3362 23295463

25 Raappana A, Koivukangas J, Ebeling T, Pirilä T. Incidence of pituitary adenomas in Northern Finland in 1992-2007. J Clin Endocrinol Metab 2010; 95:4268-75.10.1210/jc.2010-0537 20534753

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

 
Contenidos relacionados
Los editores le recomiendan continuar con las siguientes lecturas: